Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

New technology is evolving lung cancer detection and treatment at Ascension Sacred Heart Bay. It’s called the ‘Ion ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

After her shocking lung cancer diagnosis, the late Susan Wojcicki dedicated herself to fighting the disease and looking for ...

Dr. Bharat said the current recommendation for an annual lung cancer screening is for adults 50 and up who are smokers or ...

November is Lung Cancer Awareness Month, and Mercy Hospital is shining a spotlight on the life-saving power of early ...

Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy ...

The health impacts of men losing their Y chromosome from their cells are increasingly coming to light, with the loss playing ...

Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...

With 18.7% of eligible adults reporting being up to date on lung cancer screening in a national survey, this was estimated to ...

Early detection of lung cancer can drastically improve survival rates. Sponsored by Virginia Mason Franciscan Health.

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).